These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35726302)

  • 21. Clinical value and expression of Homer 1, homocysteine, S-adenosyl-l-homocysteine, fibroblast growth factors 23 in coronary heart disease.
    Zhang Z; Wang L; Zhan Y; Xie C; Xiang Y; Chen D; Wu Y
    BMC Cardiovasc Disord; 2022 May; 22(1):215. PubMed ID: 35546659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation between Levels of Serum Lipoprotein-Associated Phospholipase A2 and Soluble Suppression of Tumorigenicity 2 and Condition of Acute Heart Failure Patients and Their Predictive Value for Prognosis.
    Zhang J; Wang L; Zhao Z; Li L; Xia Y
    J Healthc Eng; 2021; 2021():1525190. PubMed ID: 34956555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum Lp-PLA2 Level Predicting Coronary Artery Lesions in Children with Kawasaki Disease.
    Zhang X; Ya-Wang Shao ; Ya-Lan Zhang ; Yi Liu
    Heart Surg Forum; 2021 Jul; 24(4):E611-E618. PubMed ID: 34473042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study.
    Ballantyne CM; Hoogeveen RC; Bang H; Coresh J; Folsom AR; Heiss G; Sharrett AR
    Circulation; 2004 Feb; 109(7):837-42. PubMed ID: 14757686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liporotein-associated phospholipase-A2 can be a diagnostic marker inthe early stage diagnosis of acute mesenteric ischemia.
    Acar T; Koçak S; Cander B; Ergin M; Dikmetaş C
    Turk J Med Sci; 2016 Jan; 46(1):120-5. PubMed ID: 27511344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in lipoprotein-Associated phospholipase A2 activity predict coronary events and partly account for the treatment effect of pravastatin: results from the Long-Term Intervention with Pravastatin in Ischemic Disease study.
    White HD; Simes J; Stewart RA; Blankenberg S; Barnes EH; Marschner IC; Thompson P; West M; Zeller T; Colquhoun DM; Nestel P; Keech AC; Sullivan DR; Hunt D; Tonkin A;
    J Am Heart Assoc; 2013 Oct; 2(5):e000360. PubMed ID: 24152981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum lipoprotein-associated phospholipase A2 predicts the formation of carotid artery plaque and its vulnerability in anterior circulation cerebral infarction.
    Yang Y; Xue T; Zhu J; Xu J; Hu X; Wang P; Kong T; Yan Y; Yang L; Xue S
    Clin Neurol Neurosurg; 2017 Sep; 160():40-45. PubMed ID: 28644968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation of plasma galectin-3 and plasma lipoprotein-associated phospholipase A2 with the severity and prognosis of coronary artery disease.
    Wang R; Wang X; Zhang E; Li F; Zhang P; Shi J
    Am J Transl Res; 2021; 13(8):8997-9004. PubMed ID: 34540011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Usefulness of high-sensitivity C-reactive protein in predicting long-term risk of death or acute myocardial infarction in patients with unstable or stable angina pectoris or acute myocardial infarction.
    Zebrack JS; Anderson JL; Maycock CA; Horne BD; Bair TL; Muhlestein JB;
    Am J Cardiol; 2002 Jan; 89(2):145-9. PubMed ID: 11792332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum inflammatory factors such as MMP-9 are associated with post-percutaneous transluminal angioplastyacute myocardial infarction in coronary heart disease patients complicated by lower extremity arteriosclerosis obliterans.
    Shao C; Wuren B; Chi G; Ren H; Li F; Song W; Wang B; Ding M
    Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(15):38-43. PubMed ID: 38279498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relationship of lipoprotein-associated phospholipase A2 activity with the seriousness of coronary artery disease.
    Zhang H; Gao Y; Wu D; Zhang D
    BMC Cardiovasc Disord; 2020 Jun; 20(1):295. PubMed ID: 32546193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Levels and clinical significance of serum homocysteine (Hcy), high-density lipoprotein cholesterol (HDL-C), vaspin, and visfatin in elderly patients with different types of coronary heart disease.
    Guan J; Wu L; Xiao Q; Pan L
    Ann Palliat Med; 2021 May; 10(5):5679-5686. PubMed ID: 34107717
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The association between the D166E polymorphism of the lipoprotein associated phospholipase A2 and risk of myocardial infarction.
    Zhang MM; Zhang CG; Yang CJ; Zhao P; Li YL
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3960-3966. PubMed ID: 31115024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of the Relationship Between the Changes of Serum SAA, LP-PLA2, sCD40L and Carotid Atherosclerosis Plaque in Patients with Acute Cerebral Infarction.
    Xu Y; Xu Y; Li Y; Liu R; Wu A; Zhou R; Mao D
    Altern Ther Health Med; 2024 Sep; 30(9):47-53. PubMed ID: 38330557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors of atherosclerotic tissue types in single-vessel and intermediate coronary lesions: a cross-sectional study.
    Wang X; Chen Q; Xu Y; Wang Y; Yang Y; Gu M; Xu H; Zhao Y
    Lipids Health Dis; 2017 Mar; 16(1):63. PubMed ID: 28335787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic utility of lipoprotein-associated phospholipase A2 for cardiovascular outcomes in patients with stable coronary artery disease.
    Sabatine MS; Morrow DA; O'Donoghue M; Jablonksi KA; Rice MM; Solomon S; Rosenberg Y; Domanski MJ; Hsia J;
    Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2463-9. PubMed ID: 17766330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between serum adiponectin and osteoprotegerin levels and coronary heart disease severity.
    Zhang HL; Jin X
    Genet Mol Res; 2015 Sep; 14(3):11023-9. PubMed ID: 26400332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utility of lipoprotein-associated phospholipase A2 for prediction of 30-day major adverse coronary event in patients with the first anterior ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention.
    Stankovic S; Asanin M; Trifunovic D; Majkic-Singh N; Miljković A; Ignjatovic S; Mrdovic I; Matic D; Savic L; Ostojic M; Vasiljevic Z
    Clin Lab; 2012; 58(11-12):1135-44. PubMed ID: 23289182
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictive Value of Serum Lipoprotein-Associated Phospholipase A2 for Type 2 Diabetes Mellitus Complicated with Metabolic Syndrome in Elderly Patients.
    Ren J; Chang M; Song S; Zhao R; Xing X; Chang X
    Clin Lab; 2022 Aug; 68(8):. PubMed ID: 35975498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Diagnostic value of combined detection of different indicators for type 2 diabetes mellitus combined with atherosclerotic disease].
    Jiang WW; Niu JD; Qi MJ; Song YW; Dang YQ; Yang PQ; Yang J; Liu YM
    Zhonghua Yi Xue Za Zhi; 2021 Aug; 101(31):2448-2453. PubMed ID: 34399558
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.